OBJECTIVE: to investigate the hepatoprotective effect of glycyrrhizic acid (GA) against hepatic injury induced by titanium dioxide nanoparticles (NTiO 2 ) in rats. BACKGROUND: Many recent studies demonstrate that most nanoparticles (NPs) have an adverse or toxic action on liver. METHODS: NTiO2-intoxicated rats received 300 mg/kg of NTiO 2 for 14 days by gavage method. Protection group was pretreated with 10 mg/kg of GA for 7 days before NTiO 2 administration. Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were detected as biomarkers in the blood to indicate hepatic injury. Product of lipid peroxidation (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GPx) were evaluated for oxidative stress in hepatic injury. Light microscopy for histopathological studies was also done. RESULTS: Administration of NTiO 2 induced a signifi cant elevation in plasma AST, ALT and ALP. In the liver, NTiO 2 increased the oxidative stress through the increase in lipid peroxidation and decrease in SOD and GPx enzymes. Pretreatment of GA signifi cantly decreased ALT, AST and ALP, attenuated the histopathology of hepatic injury, ameliorated oxidative stress in hepatic tissue, and increased the activities of SOD and GPx. CONCLUSION: These fi ndings indicate that GA effectively protects against NTiO 2 -induced hepatotoxicity in rats and might be clinically useful (Fig. 4, Ref. 47) . Text in PDF www.elis.sk.
Introduction
The liver has been considered as the target organ for toxic effects of xenobiotics. The susceptibility of the liver to chemical injury is as much a function of its anatomical proximity to the bloodstream and gastrointestinal tract as to its ability to biotransform and concentrate xenobiotics (1) . Previous studies have shown that administration of NPs to rodents result in their accumulation in various tissues including the liver, brain and spleen (2, 3) .
Among the various metal nanomaterials, NTiO 2 is used in a variety of consumer products such as sunscreens, cosmetics, clothing, electronics, paints, and surface coatings (4, 5) . Recent scientifi c studies show that NTiO 2 can be harmful to human and animal health (6) (7) (8) . It has been reported that NTiO 2 can damage liver function and induce oxidative stress and lipid peroxidation in the rodent liver (9) (10) (11) .
Since NPs, such as NTiO 2 affect liver function and its high rate usage it seems essential to fi nd a suitable medication for neutralizing or decreasing their negative side effects. Herbal medicines derived from plant extracts are being increasingly utilized to treat a wide variety of clinical disease. More attention has been paid to protective effects of natural antioxidants against chemically induced toxicities (12, 13) .
Glycyrrhizic acid (GA) is a natural constituent of liquorice isolated from the dried root of Glycyrrhiza glabra. Salts of glycyrrhizic acid are widely used as sweeteners and aromatizers in sweets, drugs, beverages, chewing-gums, chewing tobacco and toothpastes (14) . It has been reported that high doses of GA can induce hypertension (15) . However, GA possesses numerous pharmacological effects like anti-infl ammatory, neuroprotection, anti-viral, antitumor, antioxidant (16) (17) (18) (19) (20) (21) and hepatoprotective activities (21) (22) (23) (24) (25) (26) .
No published data were available about the daily exposure doses of NTiO 2 in human. However, NTiO 2 increasing use increases the health risk of people exposed to these particles, either occupationally or environmentally. Additionally, it was shown that NTiO 2 accumulated mostly in the liver (27, 28) . Thus, we used the toxic dose of NTiO 2 to evaluate whether GA could prevent hepatotoxicity effects of NTiO 2 .
Material and methods

Animals
In this experimental study, 32 healthy and adult male Wistar rats (8-10 weeks old, 180-200 g) were used. The animals were obtained from Ahvaz Jundishapur University of Medical Sciences, Experimental Research Center, and this study was approved by the ethics committee of Jundishapur University and carried out in an ethically proper way by following the guidelines provided. The animals were kept under standard laboratory conditions (12 h-dark and 12 h-light cycles, relative humidity of 50 ± 5 % and 22 ± 3 °C) for at least one week before the experiment and those conditions were preserved until the end of experiment. Animal cages were kept clean, and commercial food (pellet) and water were provided ad libitum.
Experimental design
The rats were randomly divided into 4 groups of 8 animals each as follows:
Group 1: Control group; received saline by gavage for 21 days Group 2: GA group; received 10 mg/kg GA by gavage for 21 days. Group 3: NTiO 2 -intoxicated group; 0.2 ml saline was administered for 7 days, and then 300 mg/kg NTiO 2 was given for 14 days. Group4: Protection group; 10 mg/kg GA was administered for 7 days, and then GA (10 mg/kg) plus NTiO 2 (300 mg/kg) was given for 14 days. The doses of NTiO 2 (Sigma) were selected according to previous studies that demonstrated signifi cant toxicity in rodents (29) . The doses of NTiO 2 (Sigma) were selected according to previous studies that demonstrated signifi cant toxicity in rodents (29) .
After characterization of NTiO 2 (results not shown), the stock solution (2 mg/ml) was prepared in Milli-Q water and dispersed for 10 min by using a sonicator. The stock solution of NTiO 2 was kept at 4 °C and used within 1 week for the experiments. Just before use, the stock solution diluted in Milli-Q water and prepared by ultrasonication (Solid State/Ultrasonic FS-14; Fisher Scientifi c) for 15 min to prevent aggregation. To ensure non-aggregation of NTiO 2 before administration, the time interval from preparation to oral gavage was strictly limited in less than 20 min. In addition, 20 min after the preparation, the particle size of NTiO 2 was analyzed by atomic force microscopy (AFM). GA (Sigma) was diluted in saline. The dose of GA was selected based on the results of previous studies (24, 30) . One day after the last administration, after blood sampling, the rats were sacrifi ced by cervical dislocation under ether anesthesia and livers from each animal were removed quickly and weighed. Small pieces of liver were stored separately in a deep freezer (-80 °C) for MDA, SOD and GPx assays. Other pieces were fi xed in 10 % buffered formalin.
Biochemical tests
The blood samples were collected in heparinised centrifuge tube and centrifuged. The plasma enzyme levels including plasma alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were determined spectrophotometrically from plasma samples using commercially available kits (Sigma).
Estimation of lipid peroxidation
The degree of lipid peroxidation in liver tissue homogenate of all the experimental animals was determined in terms of thiobarbituric acid reactive substances (TBARS) formation as previously described (31) . A volume of 500 μl of supernatant was mixed with 1.5 ml trichloroacetic acid (10 %) and after centrifugation (4,000× g for 10 min), 1.5 ml of supernatant was added to 2 ml TBA (0.67 %) and heated at 100 °C for 30 min. After cooling, the sample was extracted with 2 ml n-butanol and after centrifugation at 4,000× g for 15 min, the organic phase was collected. The absorbance was read spectrophotometrically at 535 nm. Values were expressed as nmol/mg tissue
Superoxide dismutase (SOD) activity assay
The assay for SOD activity was made according to the method of Suttle (32) using Ransod kit (Randox Labs., Crumlin, UK). This method is based on formation of red formazan from the reaction of 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride and superoxide radical (produced in the incubation medium from xanthine oxidase reaction), which is assayed in a spectrophotometer at 505 nm. The inhibition of the produced chromogen is proportional to the activity of SOD present in the sample. A 50 % inhibition is defi ned as 1 unit of SOD, and specifi c activity is expressed as units per milligram of tissue.
Glutathione peroxidase (GPx) activity assay
GPx activity was determined using the Ransel kit (Randox Labs., Crumlin, UK) according to Paglia and Valentine (1971) (33) . GPx catalyzes the oxidation of glutathione by cumene hydroperoxide. In the presence of glutathione reductase and NADPH, the oxidized Glutathione (GSSG) was immediately converted to the reduced form with a concomitant oxidation of NADPH to NADP+. The decrease in absorbance was monitored with a spectrophotometer at 340 nm. One GPx unit is defi ned as 1 μmol of NADPH consumed per minute, and specifi c activity is reported as units per milligram of tissue.
Histopathology analyses.
The formalin-fi xed samples were embedded in paraffi n, sectioned (5 μm) and stained with haematoxylin and eosin (H&E) for histopathology. Six stained microscopy slides per animal were examined microscopically for signs of histopathological features such as necrosis or infl ammatory-cell infi ltration, hepatocyte vacuolization (fatty deposits) and congestion of red blood cells (RBC).
Statistical analysis
The data were analyzed using one-way ANOVA followed by post hoc LSD test and were presented as mean ± SD while p < 0.05 was considered signifi cant.
Results
Nanoparticle characterizations
AFM revealed the size and morphology of the synthesized particles. The complexes appear spherical with a mean size that is inferior to 100 nm as can be seen in Figure 1 .
Biochemical tests
GA group showed slightly lower plasma levels of ALT, AST and ALP compared to control group, but the decrease was not signifi cant. Plasma levels of all biochemical tests were signifi cantly increased in NTiO 2 group (p < 0.001). In GA + NTiO 2 -treated rats, a signifi cant reduction in the biochemical tests were observed in comparison to NTiO 2 -intoxicated rats (p < 0.01). These fi ndings are depicted in Figure 2 .
MDA level, SOD and GPx activities
The administration of NTiO 2 signifi cantly increased the hepatic level of MDA when compared with the control animals. This elevation was attenuated by GA (p < 0.01). GPx and SOD activities were signifi cantly decreased with NTiO 2 compared to the control group (p < 0.01). Pre-administration of GA caused a signifi cant increase in SOD and GPx when compared to NTiO 2 -intoxicated rats. The effects of NTiO 2 and GA on MDA, SOD and GPx are reported in Figure 3 .
Histological analysis
Under light microscope, liver lobular structures in control and GA groups were clear and regular, and single layer of hepatocytes was arranged around the central vein in a radial pattern (Fig. 4A) . In NTiO 2 -intoxicated rats the normal liver lobular structures were damaged. The hepatocytes showed vacuolization and congestion of RBCs. Infi ltration of infl ammatory cells was also observed (Fig. 4B ). These pathological changes were effectively inhibited by GA ( Fig. 4C ).
Discussion
Many studies have shown toxic effects of NPs but very little attention has been directed towards the neutralizing or decreasing their toxicity. To our knowledge, this is the fi rst study that demonstrates the protective effect of a natural product against cytotoxicity induced by NPs. In this study, the protective effects of GA against NTiO 2 -induced hepatotoxicity were investigated. With a histopathological observation, it was possible to determine alterations in liver morphology, such as destruction of lobular structure, vacuolization of hepatocytes (fat deposits), congestion of RBC and infi ltration of leukocytes in NTiO 2 -intoxicated rats.
Hepatocytes fatty deposits might be due to lipid peroxidation that leads to rough endoplasmic damage and detachment of the cytoplasmic lipoprotein. These fi ndings indicate abnormal fat metabolism (34) . The abnormal retention of lipids in hepatocytes induced by NTiO 2 might indicate toxic injury to the liver in form of hepatocytes liposis by these particles. These results are in agreement with those of the previous investigation describing histologi- (10) . In this study, the histopathological alterations were signifi cantly attenuated by GA. GA improved lobular structure, and decreased vacuolization of hepatocytes (fat deposits), congestion of RBC and infi ltration of leukocytes. NTiO 2 signifi cantly elevated the plasma levels of ALT, AST and ALP. The plasma levels of these enzymes are the main indexes which refl ect liver injury (35, 36) . The rise in plasma AST and ALT has been attributed to the damaged structural integrity of the liver, because these are cytoplasmic in location and are released into circulation after cellular damage. ALP is localized to the bile canalicular pole of hepatocytes. In a diseased liver, this bile duct is often blocked, keeping fl uid within the liver. ALP accumulates and eventually escapes into the bloodstream (35) .
The reversal of alleviation of plasma enzyme activity in NTiO 2induced hepatic damage by GA could explain the prevention of leakage of intracellular enzymes by its membrane stabilizing activity.
Previous scientifi c researches demonstrate that NTiO 2 induces oxidative stress and lipid peroxidation in the liver of rodents. Shukla et al show that NTiO 2 induces oxidative DNA damage and apoptosis in human liver cells (37) . The role of oxidative stress in the mechanism of NPs-induced hepatotoxicity has also been reported by Sha et al (38) .
In this study, MDA concentration in liver tissue was significantly increased by NTiO 2 . MDA content is an index of intensifi ed peroxidation process. GA could attenuate the NTiO 2 -induced increase in the hepatic MDA content. Kiso et al demonstrate that GA can reduce lipid peroxidation (39) . Wu et al also showed that 18beta-glycyrrhetinic acid prevents free fatty acid-induced hepatic lipotoxicity (40) . As mentioned above histopathological analysis of our study also showed that GA effectively reduced the fatty deposits within the hepatocytes.
Oxidative stress is considered as a major risk factor that contributes to the increase in lipid peroxidation and declines the antioxidants in some degenerative diseases. Oxidative stress has been implicated as one of several mechanisms that have induced toxic effects in different organs due to enhanced production of oxygen free radicals (21) .
The body has an effective defense mechanism to prevent and neutralize the free radical-induced damage. This is profi cient by a set of endogenous antioxidant enzymes such as SOD and GPx. 
WBC
These enzymes constitute a mutually supportive team of defense against reactive oxygen species (ROS) (41) .
The observed signifi cantly reduced activities of SOD and GPx point out the hepatic damage in the rats administered with NTiO 2 but treatment with GA showed signifi cant increase in the level of these enzymes which indicates the antioxidant activity of the GA.
Kao et al. showed that GA treatment decreased the ROS content by elevating the activities of GPx and catalase in PC12 cells (42) . Rahman et al. demonstrate that GA exerts chemopreventive activity against lead acetate-induced hepatic oxidative stress (43) .
Numerous scientifi c studies also suggest that GA has benefi cial effects on the liver (22) (23) (24) (25) (26) . Kiso et al proposed that the antioxidative action of GA plays an important role in its hepatoprotective effects against carbon tetrachloride-induced liver injury (39). Tsai et al. have been shown that GA represses total parenteral nutritionassociated acute liver injury in rats by suppressing the endoplasmic reticulum stress (26) . Korenaga et al have been reported that GA-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice (44) .
The exact mechanism of GA protection of hepatic injury against NTiO 2 is not obtained from this study. However, the reduction in AST, ALT and ALP levels indicates that GA probably reduces necrosis or apoptosis of hepatocytes. Additionally, MDA content which indicates lipid peroxidation was decreased by GA. On the other hand, GA signifi cantly increased the antioxidant activity.
Some researchers have shown that GA induces hypertension and renal damage (15, 45) . However, in this study, renal tissues were normal and plasma levels of BUN, Cr and uric acid were not signifi cantly changed in GA (100 mg/kg) treated animals compared to control group (results not shown). Li et al have shown that pretreatment with 200 mg/kg GA improves nephrotic syndrome induced by adriamycin in rats (46) . They have also reported that GA reduces the mean arterial blood pressure. Sohn et al have also demonstrated that glycyrrhizin treatment (200 mg/kg) ameliorates renal defects in rats with acute renal failure induced by gentamicin (47) .
Conclusion
In conclusion, the biochemical results antioxidant enzyme assessment and histopathological fi ndings found in the present data suggest that GA protects against NTiO 2 -induced hepatotoxicity. These results suggest that GA may has a potential of clinical application for treating hepatotoxicity induced by metal NPs. However, further studies will be needed to fully understand the exact mechanism of GA on NPs-induced hepatotoxicity.
